This week, the US Food and Drug Administration effectively banned Juul after ordering the e-cigarette manufacturer to remove its popular products from the market.
Experts have praised this move as significant, but they are also concerned that these efforts may not keep pace with the rapidly growing electronic cigarette industry, where young people quickly move from one product to another.
The ban by the US Food and Drug Administration (FDA) has put an end to years of controversy surrounding Juul, whose popular vaping device has been criticized for contributing to the nicotine addiction of an entire generation. In 2020, the FDA ordered the removal of mint and fruit-flavored e-cigarettes from the market, resulting in a significant blow to many of Juul's products.
Regulatory authorities stated that Juul company failed to provide sufficient evidence to evaluate the toxicity and harm of its tobacco and mint flavored electronic cigarettes, making it impossible for the FDA to "assess the potential toxicological risks of using Juul products".
Meanwhile, Juul company believes that their electronic cigarette products can help cigarette smokers quit, and they have stated their intention to fight back. On Friday, an appeals court temporarily suspended the ban, while Juul company filed an appeal.
Lauren Czaplicki, a researcher at the Bloomberg School of Public Health at Johns Hopkins University, stated that the ban still holds significant importance as it marks the first marketing ban on a brand with significant market share in the United States and on menthol-flavored products.
She pointed out that other brands such as Vuse, Logic, and NJOY have already been granted market authorization for various tobacco-flavored e-cigarette products and systems, but Juul has been denied.
A study has shown that banning flavored cigarettes is effective. George Mason University's 2020 analysis of the 2009 ban on flavored cigarettes by the US Food and Drug Administration found that it reduced smoking rates among minors by 43% and young adults by 27%.
The FDA's marketing rejection could likely have an impact," said Czaplicki. "Juul remains a popular product among young people who use e-cigarettes, and the brand has some level of recognition and cultural appeal among young people who may be prone to using nicotine.
However, while Juul still dominates the U.S. market, its popularity among young people has decreased in recent years, according to Dr. Devika Rao, a pediatric pulmonologist at UT Southwestern.
A recent federal investigation has found that Juul is only the fourth most popular product among middle and high school students, with disposable e-cigarette Puff Bar ranking first, followed by Vuse and Smok in second and third place, respectively.
We have learned from the data that Juul is not the most commonly used," Laow said. "Currently, adolescents prefer disposable cigarettes, which are devices that can be purchased online or in stores." These disposable devices cost as little as $10 and are not subject to the 2020 flavor ban, even though they use the same technology as Juul.
Monica M Zorilla, a researcher from Stanford University, stated that adolescents often employ a "whack-a-mole" approach to prevention by switching from one product to another.
Sorilla said that in 2020, the US Food and Drug Administration (FDA) prioritized enforcement actions against flavored e-cigarette devices such as Juul, but exempted disposable e-cigarettes and mint-flavored e-cigarette products.
A study from Stanford University has found that teenagers are subsequently moving to exempted e-cigarettes. Zollinger said, "Teens are transitioning from pod-based [like Juul] to disposable ones like Puff Bars.
As a young person told me, anything with fruit flavors is very popular among their peers. This is partly due to regulations, but also because disposable e-cigarettes continue to come in a variety of flavors.
According to Lao, social media marketing is shrewd and devious, resulting in teenagers switching to addictive products unbeknownst to adults.
She pointed out that the latest trend is in so-called "healthy smoking devices," which are not even marketed as electronic cigarettes. "You can inhale things like melatonin or vitamins to feel better and fall asleep faster. These are essentially disguised drug delivery devices, with companies not required to disclose the concentration or content of these products." The newer products bring a whole new level of risk.
Chapleau emphasized the need for increased regulation. They suggested that the U.S. Food and Drug Administration (FDA) should issue an immediate order to remove all unauthorized e-cigarette products from retail shelves and online markets.
This will include Puff Bar," she said. "Reducing the number and types of flavored electronic cigarette devices sold in the United States may have a substantial impact on reducing youth smoking. However, it is unlikely to diminish the role tobacco-flavored e-cigarettes play in helping adult smokers quit completely.
Lao believes that smoking tobacco is leading to a new generation becoming addicted to nicotine - researchers are still exploring how to treat nicotine addiction in children rather than adults.
These products are generally believed to be less harmful than smoking, but they still carry risks as teenagers may become addicted to them.
Lao, who cares for patients at Children's Medical Center in Dallas, explains that Juul has come up with a way to make nicotine more potent, delivering a stronger hit to the brain, resulting in greater pleasure for users of vaping products.
Lao stated that "just a few puffs of a vape could potentially affect school and athletic performance, as well as cause serious long-term consequences such as lung damage, before they become addicted. Research also suggests that drug use can lead to increased heart rate and blood pressure.
She said that during the pandemic, drug use rates decreased for two years, but doctors are now concerned that the reestablishment of social networks and relaxation of restrictions could lead to a rise in these rates once again.
When I talk to my patients, either they're using drugs or their friends are using drugs and they feel pressured to start using them," said Rao.
Parents and educators need to have these conversations to understand the potential risks.
Source: The Guardian
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
